22-43928847-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_025225.3(PNPLA3):āc.444C>Gā(p.Ile148Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.232 in 1,605,646 control chromosomes in the GnomAD database, including 47,788 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity,risk factor (no stars).
Frequency
Genomes: š 0.23 ( 4560 hom., cov: 30)
Exomes š: 0.23 ( 43228 hom. )
Consequence
PNPLA3
NM_025225.3 missense
NM_025225.3 missense
Scores
1
5
12
Clinical Significance
Conservation
PhyloP100: -1.14
Genes affected
PNPLA3 (HGNC:18590): (patatin like phospholipase domain containing 3) The protein encoded by this gene is a triacylglycerol lipase that mediates triacylglycerol hydrolysis in adipocytes. The encoded protein, which appears to be membrane bound, may be involved in the balance of energy usage/storage in adipocytes. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0025928915).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.415 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PNPLA3 | NM_025225.3 | c.444C>G | p.Ile148Met | missense_variant | 3/9 | ENST00000216180.8 | NP_079501.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PNPLA3 | ENST00000216180.8 | c.444C>G | p.Ile148Met | missense_variant | 3/9 | 1 | NM_025225.3 | ENSP00000216180 | P1 | |
PNPLA3 | ENST00000423180.2 | c.432C>G | p.Ile144Met | missense_variant | 3/9 | 2 | ENSP00000397987 | |||
PNPLA3 | ENST00000478713.1 | n.478C>G | non_coding_transcript_exon_variant | 3/4 | 2 | |||||
PNPLA3 | ENST00000406117.6 | c.*76C>G | 3_prime_UTR_variant, NMD_transcript_variant | 3/10 | 2 | ENSP00000384668 |
Frequencies
GnomAD3 genomes AF: 0.228 AC: 34600AN: 151568Hom.: 4559 Cov.: 30
GnomAD3 genomes
AF:
AC:
34600
AN:
151568
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.278 AC: 69773AN: 251130Hom.: 11863 AF XY: 0.267 AC XY: 36253AN XY: 135724
GnomAD3 exomes
AF:
AC:
69773
AN:
251130
Hom.:
AF XY:
AC XY:
36253
AN XY:
135724
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.233 AC: 338062AN: 1453960Hom.: 43228 Cov.: 35 AF XY: 0.232 AC XY: 167729AN XY: 723764
GnomAD4 exome
AF:
AC:
338062
AN:
1453960
Hom.:
Cov.:
35
AF XY:
AC XY:
167729
AN XY:
723764
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.228 AC: 34605AN: 151686Hom.: 4560 Cov.: 30 AF XY: 0.233 AC XY: 17303AN XY: 74116
GnomAD4 genome
AF:
AC:
34605
AN:
151686
Hom.:
Cov.:
30
AF XY:
AC XY:
17303
AN XY:
74116
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
803
ALSPAC
AF:
AC:
838
ESP6500AA
AF:
AC:
639
ESP6500EA
AF:
AC:
1901
ExAC
AF:
AC:
31970
Asia WGS
AF:
AC:
1027
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity; risk factor
Submissions summary: Pathogenic:1Uncertain:1Benign:3Other:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 03, 2020 | This variant is associated with the following publications: (PMID: 24417250, 26264356, 25273282, 22001757, 25646328, 25290313, 23808989, 25543233, 24828988, 24074360, 24269995, 24102786, 25232397, 30649436, 30802989, 25378656, 30161167, 24009255, 30308089, 29632382, 29083408, 28073161, 28902428, 28950858, 18820647, 22258181, 23042597, 22719190, 24155878, 22100032, 20373368, 22898488, 19946271, 26690388, 21254164, 25678388, 21423719, 20648472, 19738004, 25146957, 20803499, 20546964, 19844213, 22978414, 22878467, 24670599, 24369119, 24972532, 22338072, 22724004, 26200108, 22087248, 25763607, 23023705, 23176674, 23510779, 21168459, 22792295, 24531328, 26439088, 19224197, 19542081, 19729411, 19651814, 21878620, 20034933, 23069476, 22140488, 24081230, 23505555, 26148245, 27346686, 25171251, 25581573, 27346685, 26482880, 28008009) - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2024 | PNPLA3: PM1, PP4 - |
NAFLD1 Benign:1Other:1
risk factor, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 12, 2021 | proposed classification - variant undergoing re-assessment, contact laboratory - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Hepatic steatosis Pathogenic:1
Likely risk allele, criteria provided, single submitter | clinical testing | Clinical Genomics Laboratory, Washington University in St. Louis | May 07, 2024 | The PNPLA3 c.444C>G (p.Ile148Met) variant, has been reported to be a risk allele for nonalcoholic fatty liver disease in adults and youth with an odds ratio of 2.8; 95% CI 1.5-5.2 (Romeo S et al., PMID: 18820647; Santoro N et al., 20803499; Sookoian S et al., PMID: 19738004). The highest population minor allele frequency in the population database genome aggregation database (v2.1.1) is 54.9% in the American population. This variant may increase risk for hepatic steatosis along with other genetic and environmental factors and based on available information and the ClinGen Low Penetrance/Risk Allele Working Group recommendations (Schmidt RJ et al., PMID: 38054408) this variant is classified as a likely risk allele. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;.
MutationTaster
Benign
P;P
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D
REVEL
Uncertain
Sift
Benign
T;T
Sift4G
Uncertain
D;D
Polyphen
D;.
Vest4
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at